RS51789B - Mimetička tela koja vezuju receptore melanokortina, smese, postupci i upotrebe - Google Patents

Mimetička tela koja vezuju receptore melanokortina, smese, postupci i upotrebe

Info

Publication number
RS51789B
RS51789B RS20110230A RSP20110230A RS51789B RS 51789 B RS51789 B RS 51789B RS 20110230 A RS20110230 A RS 20110230A RS P20110230 A RSP20110230 A RS P20110230A RS 51789 B RS51789 B RS 51789B
Authority
RS
Serbia
Prior art keywords
seq
polypeptide
cell
alpha
polypeptide according
Prior art date
Application number
RS20110230A
Other languages
English (en)
Serbian (sr)
Inventor
Mark Cunningham
Vedrana STOJANOVIĆ-SUSULIĆ
Karyn O`NEIL
Chichi Huang
Jeffrey Luo
Original Assignee
Centocor Ortho Biotech Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Ortho Biotech Inc. filed Critical Centocor Ortho Biotech Inc.
Publication of RS51789B publication Critical patent/RS51789B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1796—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RS20110230A 2004-10-25 2005-10-25 Mimetička tela koja vezuju receptore melanokortina, smese, postupci i upotrebe RS51789B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62196004P 2004-10-25 2004-10-25

Publications (1)

Publication Number Publication Date
RS51789B true RS51789B (sr) 2011-12-31

Family

ID=36228385

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20110230A RS51789B (sr) 2004-10-25 2005-10-25 Mimetička tela koja vezuju receptore melanokortina, smese, postupci i upotrebe

Country Status (28)

Country Link
US (1) US20060105951A1 (enExample)
EP (1) EP1812046B1 (enExample)
JP (1) JP2008517605A (enExample)
KR (1) KR101255140B1 (enExample)
CN (1) CN101437540B (enExample)
AT (1) ATE501731T1 (enExample)
AU (1) AU2005299440B2 (enExample)
BR (1) BRPI0518411A2 (enExample)
CA (1) CA2585287A1 (enExample)
CY (1) CY1111486T1 (enExample)
DE (1) DE602005026970D1 (enExample)
DK (1) DK1812046T3 (enExample)
EA (1) EA200700944A1 (enExample)
EC (1) ECSP077416A (enExample)
ES (1) ES2363023T3 (enExample)
HR (1) HRP20110405T1 (enExample)
IL (1) IL182683A0 (enExample)
MA (1) MA28943B1 (enExample)
ME (1) ME01234B (enExample)
MX (1) MX2007004974A (enExample)
NO (1) NO20072499L (enExample)
PL (1) PL1812046T3 (enExample)
PT (1) PT1812046E (enExample)
RS (1) RS51789B (enExample)
SI (1) SI1812046T1 (enExample)
TN (1) TNSN07157A1 (enExample)
WO (1) WO2006047535A2 (enExample)
ZA (1) ZA200704260B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910101B2 (en) * 2004-10-25 2011-03-22 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
US7790671B2 (en) * 2005-10-07 2010-09-07 Codman & Shurtleff, Inc. Implantable pump for protein delivery for obesity control by drug infusion into the brain
CA2727317C (en) 2008-06-09 2015-02-17 Palatin Technologies, Inc. Melanocortin receptor-specific peptides for treatment of sexual dysfunction
US20090305960A1 (en) * 2008-06-09 2009-12-10 Palatin Technologies, Inc Melanocortin Receptor-Specific Peptides for Treatment of Obesity / 669
US8614185B2 (en) * 2009-05-04 2013-12-24 Centocor Ortho Biotech Inc. Fusion proteins of alpha-MSH derivatives and Fc
WO2010144341A2 (en) 2009-06-08 2010-12-16 Palatin Technologies, Inc. Lactam-bridged melanocortin receptor-specific peptides
UY32690A (es) 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
CA2761607C (en) 2009-06-08 2018-09-04 Yi-Qun Shi Melanocortin receptor-specific peptides
CA2781402C (en) 2009-11-23 2017-03-21 Palatin Technologies, Inc. Melanocortin-1 receptor-specific cyclic peptides
EA201290295A1 (ru) 2009-11-23 2013-01-30 Палатин Текнолоджиз, Инк. Специфичные к рецептору меланокортина-1 линейные пептиды
JP2020141710A (ja) * 2011-07-06 2020-09-10 ゲンマブ エー／エス 抗体重鎖のｃ末端の修飾による補体依存性細胞傷害の調節
CN113272330B (zh) * 2019-03-02 2024-07-26 南通壹宸生物医药科技有限公司 一种双特异抗体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01005818A (es) * 1998-12-09 2003-07-21 Eleanor Rooseveltl Inst Composicion y metodo para la regulacion del peso del cuerpo y condiciones asociadas.
WO2002006316A2 (en) * 2000-07-14 2002-01-24 Zycos, Inc. Alpha-msh related compounds and methods of use
CA2490411A1 (en) * 2002-06-28 2004-01-08 Centocor, Inc. Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
EP1545608A4 (en) * 2002-06-28 2006-09-13 Centocor Inc CH1-DELETED MAMMED MUICETIC BODIES, COMPOSITIONS, METHODS AND APPLICATIONS
CA2563379A1 (en) * 2004-03-31 2005-10-20 Centocor, Inc. Human glp-1 mimetibodies, compositions, methods and uses

Also Published As

Publication number Publication date
MX2007004974A (es) 2007-10-17
NO20072499L (no) 2007-07-16
WO2006047535A2 (en) 2006-05-04
HK1106445A1 (en) 2008-03-14
US20060105951A1 (en) 2006-05-18
CN101437540B (zh) 2012-12-19
CA2585287A1 (en) 2006-05-04
ES2363023T3 (es) 2011-07-19
EP1812046A2 (en) 2007-08-01
JP2008517605A (ja) 2008-05-29
SI1812046T1 (sl) 2011-06-30
ZA200704260B (en) 2009-03-25
EA200700944A1 (ru) 2008-04-28
AU2005299440B2 (en) 2011-12-15
ME01234B (me) 2013-06-20
EP1812046A4 (en) 2009-11-11
DE602005026970D1 (de) 2011-04-28
AU2005299440A1 (en) 2006-05-04
PL1812046T3 (pl) 2011-08-31
PT1812046E (pt) 2011-06-28
HRP20110405T1 (hr) 2011-06-30
MA28943B1 (fr) 2007-10-01
CY1111486T1 (el) 2015-08-05
BRPI0518411A2 (pt) 2008-11-18
KR101255140B1 (ko) 2013-04-22
WO2006047535A3 (en) 2008-09-04
ATE501731T1 (de) 2011-04-15
TNSN07157A1 (en) 2008-11-21
IL182683A0 (en) 2007-09-20
ECSP077416A (es) 2007-05-30
CN101437540A (zh) 2009-05-20
DK1812046T3 (da) 2011-06-06
EP1812046B1 (en) 2011-03-16
KR20070085416A (ko) 2007-08-27

Similar Documents

Publication Publication Date Title
EP2214690B1 (en) Melanocortin receptor binding mimetibodies, compositions, methods and uses
US8722615B2 (en) Compositions and methods for increasing serum half-life
US8043616B2 (en) sRAGE mimetibody, compositions, methods and uses
EP3060235B1 (en) Endoglin peptides to treat fibrotic diseases
EP1812046B1 (en) Melanocortin receptor binding mimetibodies, compositions, methods and uses
JP5751641B2 (ja) メラノコルチン受容体結合コンジュゲート
AU2016332062A1 (en) Treatment of bile acid disorders
CN114591415A (zh) Glp-1/gcg双受体激动剂多肽及其融合蛋白
TW202317607A (zh) 融合蛋白及其應用
EP1792626B1 (en) Treatment of obesity with alpha-MSH mimetibodies
WO2006138610A2 (en) Interferon-alpha/beta binding fusion proteins and therapeutic uses thereof
HK1106445B (en) Melanocortin receptor binding mimetibodies, compositions, methods and uses
CA2704446A1 (en) Melanocortin receptor binding mimetibodies, compositions, methods and uses
HK1228288A1 (en) Endoglin peptides to treat fibrotic diseases
HK1228288B (en) Endoglin peptides to treat fibrotic diseases